STOCK TITAN

Renaissance Technologies Files Schedule 13G/A for INVA, 4.76M Shares

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

Renaissance Technologies LLC and Renaissance Technologies Holdings Corporation report beneficial ownership of 4,760,832 shares of Innoviva, Inc. common stock (CUSIP 45781M101), representing 7.56% of the outstanding class. The filing shows the reporting persons have sole voting and sole dispositive power over these shares. The statement is made on a Schedule 13G/A and includes a certification that the shares are held in the ordinary course of business and not for the purpose of changing or influencing control of the issuer. Certain funds managed by Renaissance may have rights to dividends or sale proceeds related to these securities.

Positive

  • Material ownership disclosed: Renaissance beneficially owns 4,760,832 INVA shares, a significant 7.56% stake.
  • Clear control of position: Reporting persons have sole voting and sole dispositive power over the shares.
  • Passive intent certified: The filing states the securities are held in the ordinary course of business and not to influence control.

Negative

  • None.

Insights

TL;DR: Renaissance holds a material, passive stake of 4.76M INVA shares (7.56%), with sole voting and dispositive power.

The reported position is large enough to be material to investors because it exceeds 5% of the class, but the Schedule 13G/A classification and the certification indicate the stake is held passively in the ordinary course of business. The sole voting and dispositive power figures clarify that Renaissance controls the trading and voting of the position, which could affect liquidity or block trades, but no intent to influence control is stated in the filing.

TL;DR: A >5% holding with sole voting rights warrants monitoring, but the filer certifies passive intent under Schedule 13G/A.

From a governance perspective, the combination of a material ownership stake and sole voting authority means Renaissance is a prominent holder whose voting decisions could matter in close corporate votes. However, the explicit certification that the shares are not held to change control frames this as a passive disclosure rather than an activist signal. No governance actions or group affiliations are disclosed in the filing.






Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



Renaissance Technologies LLC
Signature:Brian Felczak
Name/Title:Chief Financial Officer
Date:08/13/2025
Renaissance Technologies Holdings Corporation
Signature:Brian Felczak
Name/Title:Vice President
Date:08/13/2025
Exhibit Information

In accordance with Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended, each of the undersigned agrees to the filing on behalf of each of a Statement on Schedule 13G, and all amendments thereto, with respect to the shares of Common Stock, par value $0.01 per share of Innoviva, Inc.

FAQ

How many Innoviva (INVA) shares does Renaissance Technologies report owning?

The filing reports beneficial ownership of 4,760,832 shares of Innoviva common stock.

What percentage of INVA does Renaissance Technologies own?

Renaissance's position represents 7.56% of Innoviva's outstanding common stock.

Does Renaissance have voting control over its INVA shares?

Yes, the filing reports sole voting power and sole dispositive power over the 4,760,832 shares.

Is the Renaissance stake in INVA active or passive?

The Schedule 13G/A includes a certification that the shares are held in the ordinary course of business and not to change or influence control, indicating a passive position.

Are any other parties reported as having rights to INVA dividends or proceeds?

The filing states that certain funds managed by Renaissance have the right to receive dividends and proceeds related to these securities.
Innoviva

NASDAQ:INVA

View INVA Stock Overview

INVA Rankings

INVA Latest News

INVA Latest SEC Filings

INVA Stock Data

1.63B
73.28M
Biotechnology
Pharmaceutical Preparations
Link
United States
BURLINGAME